Results
|
2861.
|
|
|
2862.
|
|
|
2863.
|
|
|
2864.
|
|
|
2865.
|
|
|
2866.
|
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors. [electronic resource] by
- Sakimura, Riku
- Tanaka, Kazuhiro
- Nakatani, Fumihiko
- Matsunobu, Tomoya
- Li, Xu
- Hanada, Masuo
- Okada, Takamitsu
- Nakamura, Tomoyuki
- Matsumoto, Yoshihiro
- Iwamoto, Yukihide
Producer: 20050901
In:
International journal of cancer vol. 116
Availability: No items available.
|
|
2867.
|
|
|
2868.
|
|
|
2869.
|
|
|
2870.
|
|
|
2871.
|
|
|
2872.
|
|
|
2873.
|
Ethanol disrupts vascular endothelial barrier: implication in cancer metastasis. [electronic resource] by
- Xu, Mei
- Chen, Gang
- Fu, Wei
- Liao, Mingjun
- Frank, Jacqueline A
- Bower, Kimberly A
- Fang, Shengyun
- Zhang, Zhuo
- Shi, Xianglin
- Luo, Jia
Producer: 20120808
In:
Toxicological sciences : an official journal of the Society of Toxicology vol. 127
Availability: No items available.
|
|
2874.
|
|
|
2875.
|
Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma. [electronic resource] by
- Horwitz, S
- Coiffier, B
- Foss, F
- Prince, H M
- Sokol, L
- Greenwood, M
- Caballero, D
- Morschhauser, F
- Pinter-Brown, L
- Iyer, S P
- Shustov, A
- Nichols, J
- Balser, J
- Balser, B
- Pro, B
Producer: 20160209
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
2876.
|
Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas. [electronic resource] by
- Aspeslagh, Sandrine
- Stein, Mark
- Bahleda, Rastilav
- Hollebecque, Antoine
- Salles, Gilles
- Gyan, Emmanuel
- Fudio, Salvador
- Extremera, Sonia
- Alfaro, Vicente
- Soto-Matos, Arturo
- Soria, Jean-Charles
Producer: 20171106
In:
Anti-cancer drugs vol. 28
Availability: No items available.
|
|
2877.
|
|
|
2878.
|
|
|
2879.
|
|
|
2880.
|
|